The 250,000 square-foot facility located in Cantanhede, Portugal serves as the hub for Tilray’s cultivation, processing, distribution and research of medical cannabis products in Europe NANAIMO, British Columbia --(BUSINESS WIRE)--Apr. 24, 2019-- Tilray (NASDAQ:TLRY), a global pioneer in the

NANAIMO, British Columbia --(BUSINESS WIRE)--Apr. 23, 2019-- Tilray Inc. (Nasdaq: TLRY), a global leader in cannabis research and production, announced today it will report results for the first quarter ended March 31, 2019 on Tuesday, May 14, 2019 after market close.

Tilray cannabis products will be used to support the Murdoch Children’s Research Institute led pilot study to evaluate the feasibility and acceptability of a randomized placebo-controlled trial of the efficacy of cannabidiol (CBD) oral solution in reducing Severe Behavioral Problems in children

Annual NACD Directorship 100 List Recognizes the Most Influential Corporate Directors and Governance Experts NANAIMO, British Columbia --(BUSINESS WIRE)--Mar. 26, 2019-- The National Association of Corporate Directors (NACD) announced the 2019 NACD Directorship 100, a list of the most influential